首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 傷口護理 > 全球的創傷管理:2007年至2016年
產業/市場分類
醫療設備 (3974)
內視鏡檢查設備 (113)
分子呈像/呈影劑 (29)
心血管設備 (244)
可拋式醫學設備 (83)
核子醫學 (75)
病患監測 (343)
眼科設備 (100)
傷口護理 (87)
超音波 (49)
齒科設備 (172)
導管 (198)
整形外科 (329)
醫學影像診斷 (399)
體外診斷設備 (387)
CT/MRI/X光 (142)
e保健 (309)
市場調查報告書

全球的創傷管理:2007年至2016年

Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

出版商 MedMarket Diligence
出版日期 2007年11月 商品編碼 57736
內容資訊 英文 275 pages, 50 Exhibits, 70 Company Profiles
價格
US $ 2850 Hard Copy
US $ 2850 PDF by E-mail (Single User License)
US $ 3050 PDF by E-mail (Single User License) & Hard Copy
US $ 4350 PDF by E-mail (Site License)
US $ 5350 PDF by E-mail (Global Site License)


全球的創傷管理:2007年至2016年 是由出版商MedMarket Diligence在2007年11月所出版的。 這份英文市場調查報告書包含275 pages, 50 Exhibits, 70 Company Profiles 價格從美金2850起跳。

簡介

專門於醫療技術、醫藥、針對該市場的決策方案領域的美國市調公司 MedMarket Diligence(總公司: California state)針對全球創傷管理進行詳細的調查分析,並出版經系統整理的報告書 "Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World" 。

本報告書內容包括:現在及未來的創傷管理產品市場分析、最新技術動向、市場規模及預測、競爭企業的市場佔有率、市場機會等。內容綱要摘記如下:

實施概要

第1章 背景

  • 產業結構
  • 複雜的產業
  • 主要創傷管理企業
  • 歷史動向及技術開發
  • 全球規範及償寸環境
  • 創傷治療的地區性差異
  • 低介入性外科處置
  • 創傷管理動向
  • 市場動向

第2章 臨床背景及處理件數

  • 背景
  • 創傷種類
  • 外科創傷
  • 外傷
  • 燙傷
  • 擦傷
  • 靜脈性潰瘍
  • 動脈性潰瘍
  • 糖尿病潰瘍
  • 創傷治癒生理機能
  • 影響創傷治癒的因素
  • 主要治療分類及方法
  • 治療、成長率、動向

第3章 產品、技術及市場

  • 背景
  • 膠膜包紮
  • 透明敷料
  • 泡沫包紮
  • 海藻酸鈉包紮
  • 凝膠
  • 非黏著包紮
  • 抗菌包紮
  • 組織工程產品
  • 藥理產品
  • 物理性治療

第4章 國別市場分析

  • 全球概要
  • 市場預測
  • 美國
  • 日本
  • 德國
  • 法國
  • 義大利
  • 英國

第5章 企業介紹

  • 主要企業
  • 特殊企業

附錄

圖表

目錄

Abstract

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents

EXECUTIVE SUMMARY

Section 1: BACKGROUND

  • 1.1 Industry Structure
  • 1.2 A Complex Industry
  • 1.3 Major Wound Management Corporations
  • 1.4 Historical Perspective and Technology Breakthroughs
  • 1.5 World-Wide Regulatory and Reimbursement Environment
    • 1.5.1 Cost Effectiveness
    • 1.5.2 Clinical
    • 1.5.3 Regulatory
    • 1.5.4 Reimbursement
      • 1.5.4.1 U.S.A.
      • 1.5.4.2 European Union
      • 1.5.4.3 France
      • 1.5.4.4 Germany
      • 1.5.4.5 United Kingdom
      • 1.5.4.6 Italy
      • 1.5.4.7 Belgium
      • 1.5.4.8 Spain
      • 1.5.4.9 Scandinavia
  • 1.6 Geographical Differences in Treatments of Wounds
  • 1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
  • 1.8 Wound Management Trends
    • 1.8.1 Surgical Wounds
    • 1.8.2 Traumatic Wounds
    • 1.8.3 Burns
    • 1.8.4 Chronic Wounds
  • 1.9 Market Dynamics

Section 2: CLINICAL BACKGROUND AND CASELOAD

  • 2.1 Background
    • 2.1.1 A few figures
    • 2.1.2 Overview of functions
    • 2.1.3 Skin Anatomy: a summary
  • 2.2 Types of Wounds
    • 2.2.1 Classification By Severity
    • 2.2.2 Classification By Morphology
    • 2.2.3 Classification By Etiology
    • 2.2.4 Color Classification
  • 2.3 Surgical Wounds
  • 2.4 Traumatic Wounds
  • 2.5 Burns
    • 2.5.1 Debridement
    • 2.5.2 Grafting
  • 2.6 Pressure Ulcers
    • 2.6.1 Ulcer classification
    • 2.6.2 Hospital-acquired ulcers
    • 2.6.3 Management of pressure ulcers
  • 2.7 Venous Ulcers
  • 2.8 Arterial Ulcers
  • 2.9 Diabetic Ulcers
    • 2.9.1 Prevalence
    • 2.9.2 Stages of Diabetic Ulcer
    • 2.9.3 Treatment
      • 2.9.3.1 Amputations
      • 2.9.3.2 Abnormal Scarring
    • 2.9.4 Acquired Immunodeficiency Syndrome
  • 2.10 Wound Healing Physiology
    • 2.10.1 Inflammatory Phase
    • 2.10.2 Proliferative Phase
      • 2.10.2.1 Angiogenesis
    • 2.10.3 Maturation Phase
  • 2.11 Factors Affecting Wound Healing
    • 2.11.1 Extrinsic Factors
    • 2.11.2 Mechanical Stress
    • 2.11.3 Debris
    • 2.11.4 Temperature
    • 2.11.5 Desiccation and Maceration
    • 2.11.6 Infection
    • 2.11.7 Chemical Stress
    • 2.11.8 Medication
    • 2.11.9 Other Extrinsic Factors
    • 2.11.10 Intrinsic Factors
    • 2.11.11 Health Status
    • 2.11.12 Age Factors
    • 2.11.13 Body Build
    • 2.11.14 Nutritional Status
  • 2.12 Major Treatment Categories and Regimes
  • 2.13 Incidence of Treatments, Growth Rates and Trends

Section 3: PRODUCTS, TECHNOLOGIES AND MARKETS

  • 3.1 Background
  • 3.2 Film Dressings
    • 3.2.1 Overview
    • 3.2.2 Product Examples
    • 3.2.3 Market and Competitive Activity
  • 3.3 Hydrocolloids
    • 3.3.1 Overview
    • 3.3.2 Product Examples
    • 3.3.3 Market and Competitive Activity
  • 3.4 Foam Dressings
    • 3.4.1 Overview
    • 3.4.2 Product Examples
    • 3.4.3 Market and Competitive Activity
  • 3.5 Alginate Dressings
    • 3.5.1 Overview
    • 3.5.2 Product Examples
    • 3.5.3 Market and Competitive Activity
  • 3.6 Hydrogels
    • 3.6.1 Overview
    • 3.6.2 Product Examples
    • 3.6.3 Market and Competitive Activity
  • 3.7 Non Adherent Dressings
    • 3.7.1 Overview
    • 3.7.2 Product Examples
    • 3.7.3 Market and Competitive Activity
  • 3.8 Antimicrobial Dressings
    • 3.8.1 Overview
    • 3.8.2 Product Examples
    • 3.8.3 Market and Competitive Activity
  • 3.9 Tissue Engineered Products
    • 3.9.1 Overview
    • 3.9.2 Traditional skin grafts
    • 3.9.3 Skin replacements
    • 3.9.4 Product Examples
    • 3.9.5 Market and Competitive Analysis
  • 3.10 Pharmacological Products
    • 3.10.1 Overview
    • 3.10.2 Product Examples
      • 3.10.2.1 Growth Factors
      • 3.10.2.2 Growth factors: background
      • 3.10.2.3 Classification
      • 3.10.2.4 Regranex
      • 3.10.2.5 Other Growth Factors
      • 3.10.2.6 Non-Growth Factor Modulators
    • 3.10.3 Market and Competitive Analysis
      • 3.10.3.1 Growth Factors
      • 3.10.3.2 Non-Growth Factor Stimulants
      • 3.10.3.3 Gene Therapy
  • 3.11 Physical Treatments
    • 3.11.1 Negative Pressure Devices
    • 3.11.2 Positive Pressure Devices
    • 3.11.3 Mechanically-assisted Wound Closure
    • 3.11.4 Other Physical Wound Therapies
      • 3.11.4.1 Hydrotherapy
      • 3.11.4.2 Electrical Stimulation
      • 3.11.4.3 Electromagnetic Stimulation Devices
      • 3.11.4.4 Ultraviolet Therapy
      • 3.11.4.5 Hyperbaric Oxygen Therapy
      • 3.11.4.6 Ultrasound Devices
      • 3.11.4.7 Laser Devices
      • 3.11.4.8 Wound Imaging/Documentation
    • 3.11.5 Market and Competitive Analysis
      • 3.11.5.1 Pressure Relief Devices
      • 3.11.5.2 Hydrotherapy
      • 3.11.5.3 Electrical Stimulation
      • 3.11.5.4 Hyperbaric Oxygen Therapy

Section 4: COUNTRY MARKET ANALYSIS

  • 4.1 Global Overview
  • 4.2 Market Estimates
    • 4.2.1 Market potential
    • 4.2.2 Leading Wound Care Companies
    • 4.2.3 Leading National Markets
  • 4.3 USA
    • 4.3.1 Market Opportunity
    • 4.3.2 Market for Advanced Wound Management Products
  • 4.4 Japan
    • 4.4.1 Wound Care Market
    • 4.4.2 Market Opportunity
    • 4.4.3 Leading Companies
  • 4.5 Germany
    • 4.5.1 Wound Care Market
    • 4.5.2 Leading Companies
  • 4.6 France
    • 4.6.1 Wound Care Market
    • 4.6.2 Leading Companies
  • 4.7 Italy
    • 4.7.1 Wound Care Market
    • 4.7.2 Leading Companies
  • 4.8 United Kingdom
    • 4.8.1 Wound Care Market
    • 4.8.2 Leading Companies

Section 5: COMPANY PROFILES

  • 5.1 Major Companies
  • 5.2 Specialist Companies
    • 5.2.1 Antimicrobial Dressings
    • 5.2.2 Oxygen Therapy
    • 5.2.3 Skin Substitutes
    • 5.2.4 Hydrogels
    • 5.2.5 Growth Factors
    • 5.2.6 Odour Control
    • 5.2.7 Other Therapeutic Modalities
    • 5.2.8 Summary Profiles
Back to Top